Skip to main content

Peer Review reports

From: Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer

Original Submission
15 Jul 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
30 Jul 2022 Reviewed Reviewer Report
29 Aug 2022 Reviewed Reviewer Report
12 Sep 2022 Author responded Author comments - Edward Agyare
Resubmission - Version 3
12 Sep 2022 Submitted Manuscript version 3
22 Sep 2022 Author responded Author comments - Edward Agyare
Resubmission - Version 4
22 Sep 2022 Submitted Manuscript version 4
27 Sep 2022 Author responded Author comments - Edward Agyare
Resubmission - Version 5
27 Sep 2022 Submitted Manuscript version 5
29 Sep 2022 Author responded Author comments - Edward Agyare
Resubmission - Version 6
29 Sep 2022 Submitted Manuscript version 6
5 Oct 2022 Author responded Author comments - Edward Agyare
Resubmission - Version 7
5 Oct 2022 Submitted Manuscript version 7
30 Oct 2022 Reviewed Reviewer Report
15 Nov 2022 Reviewed Reviewer Report
26 Nov 2022 Reviewed Reviewer Report
7 Dec 2022 Author responded Author comments - Edward Agyare
Resubmission - Version 8
7 Dec 2022 Submitted Manuscript version 8
Publishing
14 Dec 2022 Editorially accepted
22 Dec 2022 Article published 10.1186/s12885-022-10449-y

You can find further information about peer review here.

Back to article page